Contracts › 75D30121C10166
75D30121C10166: Tuberculosis Trials and Consortium Services
Awarded to Denver Health and Hospital Authority by Centers for Disease Control and Prevention (CDC).
$2.3Mobligated
$3.9Mpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75D30121C10166 |
|---|---|
| Awardee | Denver Health and Hospital Authority |
| Awarding agency | Centers for Disease Control and Prevention (CDC) |
| Awarding office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CO |
| Offers received | 22 |
| Period of performance | 01 January 2021 to 31 December 2026 |
| Potential end | 31 December 2030 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record